Company Data
Passage Bio Inc.
Ticker
PASG
Current Price
$3.45 -41.33%
Market Cap
$11.1M
Price Target
Refer to Report
Volume
368.4K
52wk Range
$3.935 - $20
Overview
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.